Published on
January 9, 2024
- 16:00 GMT
Cytonus Therapeutics Enters Licensing Agreement with Medinno for HIEstem™, a Neuro-Regenerative Cellular Therapy
Cytonus obtains exclusive rights to Medinno’s HIEstem for the North American and MENA markets SAN DIEGO, CALIFORNIA, UNITED STATES, January 9, 2024 /EINPresswire.com/ -- Cytonus Therapeutics, Inc. (“Cytonus”) a biotherapeutic company developing …
Distribution channels:
Business & Economy, Healthcare & Pharmaceuticals Industry
...
